However, the p.Asp409Asn mutation in PPP4R3A not only eliminates its tumor-suppressive function but also promotes the activation of the Akt-mTOR-S6K/4E-BP pathway, thereby enhancing cell proliferation. Here, RPS6KB1 is linked to neoplasm.